'Record' ABM Seed Funding for Influ2

New York-based Influ2, which offers account-based advertising solutions for B2B marketers, has announced an initial round of seed funding totalling $3.4m. Funds are earmarked for expand its services, bringing in senior sales hires and growing its client base in healthcare and IT.

The firm promises b2b clients effective content marketing, as well as 'meaningful relationships with customers that result in closed deals', delivering targeted ads at each step of the customer journey. The platform 'identifies' every ad visitor - 'the actual person who specifically clicked on the ad', how many times and at what time(s) they interacted with its content.

Influ2, co-founded in 2018 by CEO Dmitri Lisitski (pictured left) and CTO Vladimir Mikhalko (right), says the raise is 'the largest round of seed funding secured in the history of account-based marketing (ABM)'. The company says its revenue has increased fivefold since 2019, with 251% in the first six months of 2020 despite the economic impact of the pandemic.

The round of funding was led by Boston fund One Way Ventures and Athens-based VentureFriends, plus investors including 'super angel' Murat Abdurakhamanov and Peter Harrison, former CEO of GlobalLogic.

Says Lisitski: 'Our rapid growth this past year shows that enterprises are eager to integrate this approach into their overall marketing strategies - especially since the traditional approaches to marketing, such as trade shows, are no longer available. Marketers have been more willing to innovate and embrace new trends, and person-based advertising is at the forefront of that'.

The company is online at www.influ2.com .